Efficacy of Domperidone (a Prokinetic Agent) on Time in Range in Digestively Asymptomatic Type I Diabetic Patients with Delayed Gastric Emptying (Gastro-TIR)

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

June 1, 2028

Study Completion Date

July 1, 2028

Conditions

Type 1 Diabetic

Interventions

DRUG

Domperidone 10mg

30 mg per day for 21 days

DRUG

Placebo

3 per day for 21 days

DIAGNOSTIC_TEST

gastric emptying test

Trial Locations (6)

CHU Amiens, Amiens

CHU de CAEN, Caen

CH Dieppe, Dieppe

Centre Hospitalier Intercommunal Elbeuf, Louviers, Val de Reuil, Elbeuf

GH Le Havre, Le Havre

CHU de ROUEN, Rouen

All Listed Sponsors

lead

University Hospital, Rouen

OTHER